NEW ORLEANS, Oct. 6, 2017 /PRNewswire/ -- Former Attorney
General of Louisiana, Charles C. Foti, Jr., Esq., a partner at
the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF has commenced an investigation into Alexion
Pharmaceuticals, Inc. (NASDAQ: ALXN).
Since late 2016, the Company has been the subject of investigations by numerous legal and regulatory authorities and
significant litigation relating to its use of a myriad of unethical and possibly illegal sales and promotion campaigns by its
salespeople in connection with its flagship drug, Soliris.
The actions of the Company, as directed by its executives, have exposed it to significant financial losses, an exodus of
high-level executives, investigations by the U.S. Securities and Exchange Commission, the U.S. Department of Justice, the U.S.
Attorney's Office for the District of Massachusetts, the U.S. Department of Health and Human
Services and Brazilian law enforcement officials. Further, the Company has been sued in an ongoing securities class action
lawsuit for failing to disclose material information and has also received a formal demand for inspection of its books and
records made by a shareholder. Recently, a shareholder derivative lawsuit was filed against the Company's current and
former executives.
KSF's investigation is focusing on whether Alexion's officers and/or directors breached their fiduciary duties to its
shareholders or otherwise violated state or federal laws.
If you have information that would assist KSF in its investigation, or have been a long-term holder of Alexion shares and
would like to discuss your legal rights, you may, without obligation or cost to you, call toll-free at 1-877-515-1850 or email
KSF Managing Partner Lewis Kahn (lewis.kahn@ksfcounsel.com).
About Kahn Swick & Foti, LLC
KSF, whose partners include the Former Louisiana Attorney General Charles C. Foti, Jr., is a
law firm focused on securities, antitrust and consumer class actions, along with merger & acquisition and breach of fiduciary
litigation against publicly traded companies on behalf of shareholders. The firm has offices in New
York, California and Louisiana.
To learn more about KSF, you may visit www.ksfcounsel.com.
Contact:
Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
lewis.kahn@ksfcounsel.com
1-877-515-1850
206 Covington St.
Madisonville, LA 70447
View original content with multimedia:http://www.prnewswire.com/news-releases/alexion-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick--foti-llc-investigates-the-officers-and-directors-of-alexion-pharmaceuticals-inc--alxn-300532243.html
SOURCE Kahn Swick & Foti, LLC